Medtronic PLC’s Brain Therapies business, which includes neurovascular and neurosurgery devices, was by far the company’s fastest-growing unit in the first quarter of fiscal 2020. First-quarter revenues for the business were $740m, up 11.4% on a year-over-year, constant currency basis.
“Our brain business continues to deliver exceptional results,” Medtronic CEO Omar Ishrak said during the company’s earnings call on 20...







